| Neuropathies in the context of malignancies. | |
| | |
MedLine Citation:
|
PMID: 18769246 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE OF REVIEW: To conduct a critical review of recent data pertaining to the clinical and therapeutic aspects of peripheral neuropathies in the setting of malignancies, with the exception of paraproteinemic neuropathies. Our search extended to the past 2 years, using a PubMed search strategy. RECENT FINDINGS: In the field of neuropathies linked with the development of the cancer, recent works have focused on lymphoma and cancer-associated vasculitides. In paraneoplastic syndromes, the major fact of the past 2 years is the issue of guidelines for diagnosis and treatment of these disorders, under the aegis of the paraneoplastic syndromes Euronetwork and of the European Federation of Neurological Sciences. When considering chemotherapy, neurotoxicity is becoming increasingly better known. Finally, the spectrum of late-delayed complications of irradiation further increases with a better clinical characterization of radiotherapy-induced dropped head syndrome. SUMMARY: This article successively reviews the results of the recent studies in these various fields. In the field of chemotherapy, we will particularly focus on some new data concerning oxaliplatin, bortezomib, the albumin-bound form of paclitaxel and lenalidomide. |
| | |
Authors:
|
Anthony Behin; Dimitri Psimaras; Khe Hoang-Xuan; Jean-Marc Leger |
Related Documents
:
|
6145216 - Tardive dysmentia: a reappraisal. 7118846 - A case of neuroleptic malignant syndrome successfully treated with amantadine. 16321766 - Muir-torre syndrome. 1678666 - Is the predisposition to neuroleptic malignant syndrome genetically transmitted? 6846406 - The dup(3)(p25 leads to pter) syndrome: a case with holoprosencephaly. 7670976 - Musculocutaneous nerve entrapment: a case report. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Current opinion in neurology Volume: 21 ISSN: 1350-7540 ISO Abbreviation: Curr. Opin. Neurol. Publication Date: 2008 Oct |
Date Detail:
|
Created Date: 2008-09-04 Completed Date: 2008-10-20 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9319162 Medline TA: Curr Opin Neurol Country: England |
Other Details:
|
Languages: eng Pagination: 534-9 Citation Subset: IM |
Affiliation:
|
APHP, Centre de référence de pathologie neuromusculaire Paris-Est, Bâtiment Babinski, Fédération de Neurologie Mazarin, GH Pitié-Salpêtrière, Paris, France. anthony.behin@psl.aphp.fr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antineoplastic Agents
/
pharmacology,
therapeutic use Drug Therapy / adverse effects Humans Neoplasms* / pathology, physiopathology, therapy Peripheral Nerves / drug effects, pathology, physiopathology, radiation effects Peripheral Nervous System Diseases / chemically induced, pathology*, physiopathology* PubMed Radiotherapy / adverse effects |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Diabetic polyneuropathy: an update.
Next Document: Ganglioside antibodies and neuropathies.